Specificity of CRISPR-Cas9 Editing in Exagamglogene Autotemcel — Update
Authors:
- 9 October 2025
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 393 (14) , 1440-1442
Abstract
No abstract availableFunding Information
- Vertex Pharmaceuticals (Not Applicable)
This publication has 5 references indexed in Scilit:
- Exagamglogene Autotemcel for Severe Sickle Cell DiseaseNew England Journal of Medicine, 2024
- Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaNew England Journal of Medicine, 2024
- Specificity of CRISPR-Cas9 Editing in Exagamglogene AutotemcelNew England Journal of Medicine, 2024
- Human genetic diversity alters off-target outcomes of therapeutic gene editingNature Genetics, 2022
- A global reference for human genetic variationNature, 2015